Formulation Design & Development

The Formulation Design & Development (FDD) Section is comprised of members from many diverse backgrounds in industry, regulatory and academia who share a common interest in the area of formulation design, research and development — a multidisciplinary field drawing upon the physical, chemical, biological and engineering sciences. The primary goal of this section is to unite multiple scientific disciplines in a forum where they can share experimental results, consider new formulation and dosage form technologies, and discuss issues and concerns regarding the design and development of formulations/drug products for small molecules. This Section collaboratively interfaces with other sections which focus on pre-formulation, biopharmaceutics, formulation strategies, and manufacturing process optimization. Aspects of formulation design and development include the study of dosage forms for drug delivery via all routes of administration wherein the dosage form encompasses the formulation, process by which it is made, and primary packaging. The Section's focus on product development includes evaluation of dosage form manufacturability, stability, quality and performance both in vitro and in vivo that is appropriate to its development stage.

Please check back frequently for more information about the brand new FDD Section!

The archived websites for the Pharmaceutics and Drug Delivery (PDD) Section and the
Pharmaceutical Technologies (PT) Section are still available for access.

Chair
Mansoor A. Khan, Ph.D.
FDA/CDER/DPQR, HFD-941
Silver Spring, MD UNITED STATES

Chair-Elect
Colin M. Minchom, Ph.D.
Patheon Inc.
Mississauga, ON Canada

Vice Chair
Dave Wallick, Ph.D.
The Dow Chemical Company
Midland, MI UNITED STATES

Secretary/Treasurer
Lori R. Hilden, Ph.D.
Eli Lilly & Company
Indianapolis, IN

Past Chair
Bradley A. Clark, Ph.D.
Solvay Pharmaceuticals
Marietta, GA

Annual Meeting Screeners Committee
Jayanth Panyam
Wayne State University
Detroit, MI UNITED STATES

Annual Meeting Program Committee
Colin M. Minchom, Ph.D.
Patheon Inc.
Mississauga, ON Canada

Content Advisory Cmte
Sandra M. Sims, Ph.D.

Portage, MI UNITED STATES

Student/Postdoc Committee
John Graham Eley, Ph.D.
Department of Pharmaceutical Sciences College of Pharmacy
Pocatello, ID UNITED STATES

Fellows Committee
Abu T.M. Serajuddin, Ph.D.
Novartis Pharmaceuticals Corporation
Flushing, NY United States

Nominations Committee
Mansoor A. Khan, Ph.D.
FDA/CDER/DPQR, HFD-941
Silver Spring, MD UNITED STATES

Program Coordination Committee
Colin M. Minchom, Ph.D.
Patheon Inc.
Mississauga, ON Canada

Strategic Planning
Bhaskara R. Jasti, Ph.D.
University of the Pacific
Stockton, CA UNITED STATES

Webmasters Committee
Dr. Naveen K. Bejugam
SRI International
Menlo Park, CA United States

Communications Committee
Samantha Lai, Ph.D.
Geron Corporation
Mountain View, CA United States

Member Strategic Oversight Committee
Rakhi Shah

Silver spring, MD UNITED STATES

Communications Committee
William Chekan
Capsugel
Morris Plains, NJ UNITED STATES

Executive Council Liaison
Peter A. Crooks, Ph.D.
University of Kentucky College of Pharmacy
Lexington, KY UNITED STATES

Staff Liaison
Peter Inchauteguiz
AAPS
Arlington, VA UNITED STATES

Ocular Drug Delivery & Disposition Focus Group
Srini Venkatesh, Ph.D.
Bausch and Lomb
Rochester, NY UNITED STATES

Nutraceuticals Focus Group
Mary A. Murray, Ph.D.
Nutrilite, Division Of Access Business Group
Buena Park, CA UNITED STATES

Generic Pharmaceuticals Focus Group
Mei-Ling Chen, Ph.D
Office of Pharmaceutical Science, Food and Drug Administration
Rockville, MD UNITED STATES

Inhalation & Nasal Technology Focus Group
Dr. Jill K. Sherwood
Schering-Plough Research Institute
Summit, NJ UNITED STATES

Modified Release Focus Group
Avinash G. Thombre, Ph.D.
Pfizer, Inc.
Groton, CT UNITED STATES

Lipid-Based Drug Delivery Systems Focus Group
Panayiotis P. Constantinides, Ph.D.
Biopharmaceutical and Drug Delivery Consulting, LLC
Gurnee, IL UNITED STATES

Sterile Products Focus Group
Lavinia Marina Lewis, Ph.D.
Pfizer
Chesterfield, MO United States

Animal Pharmaceutics & Technology Focus Group
Krishan Kumar, Ph.D.
Luna NanoWorks
Danville, VA UNITED STATES

Excipients Focus Group
Brian AC Carlin, Ph.D.
FMC BioPolymer
Princeton, NJ

Nanotechnology Focus Group
Patrick J. Sinko, Ph.D.
Rutgers University College of Pharmacy
Piscataway, NJ UNITED STATES

Oral Absorption Focus Group
Dr. Praveen V. Balimane
Bristol-Myers Squibb
Princeton, NJ UNITED STATES

Nucleic Acid Based Therapeutics Focus Group
Alain P. Rolland, Ph.D.
Vical Incorporated
San Diego, CA UNITED STATES

Preformulation Focus Group
Eric J. Munson, Ph.D
University of Kansas
Lawrence, KS UNITED STATES